Comparing the analgesic effect of fluoxetine and vitamin E with vitamin E only in breast pain due tofibrocystic breast disease
Phase 3
Recruiting
- Conditions
- N60.2Mastalgia.Fibroadenosis of breast
- Registration Number
- IRCT20200205046381N1
- Lead Sponsor
- Shahre-kord University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Female
- Target Recruitment
- 70
Inclusion Criteria
Women 20 to 50 years old with fibrocystic breast disease-induced mastalgia
Women with mastalgia criterion equal to or greater than four on the VAS scale
Women whose pain lasts more than 5 days per month
The patient has no known history of brest disease or malignancy
Exclusion Criteria
Women with physical and mental illnesses such as polycystic ovary disease
Obese female patients 30=BMI
Women who have been on hormone therapy for the past three months
Women who use contraceptives
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Pain. Timepoint: Baseline and two months after intervention. Method of measurement: VAS Questionaire.
- Secondary Outcome Measures
Name Time Method